3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Preleukemia
1
Myelodysplastic Syndromes
1
Leukemia
1
Hematologic Diseases
1
Cytopenia
1
Bone Marrow Diseases
1
Anemia
1
Interventions
Cyclophosphamide
63
fludarabine phosphate
52
Busulfan
48
Cyclosporine
37
Antilymphocyte Serum
36
Peripheral Blood Stem Cell Transplantation
35
Cytarabine
29
Filgrastim
28
Mycophenolic Acid
27
Whole-Body Irradiation
26
Radiotherapy
26
Melphalan
26
Cord Blood Stem Cell Transplantation
24
Tacrolimus
23
Methotrexate
23
Methylprednisolone
21
fludarabine
19
Etoposide
16
Thiotepa
11
Granulocyte Colony-Stimulating Factor
11
Azacitidine
10
Alemtuzumab
9
Daunorubicin
8
sargramostim
7
Idarubicin
7
Decitabine
7
Biopsy
7
Topotecan
6
Stem Cell Transplantation
6
Mitoxantrone
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Sertraline
×
Classical hematology
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled